Elnas, Hansel R.

HRN: 13-34-47  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2025
CEFUROXIME 1.5GM (VIAL)
03/26/2025
03/26/2025
IV
1.5gms
Now Only
STAT CS
Waiting Final Action 
03/26/2025
CEFUROXIME 1.5GM (VIAL)
03/26/2025
03/28/2025
IV
1.5g
Q8hr X 3 Doses
Sp CS
Waiting Final Action 
03/26/2025
MUPIROCIN 2%, 15G (TUBE)
03/26/2025
03/31/2025
TOPICAL
Na
OD
Sp CS
Waiting Final Action 
03/27/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/27/2025
04/03/2025
IV
900mg
Q8hrs
S/P CS With Hysterectomy + BTL
Waiting Final Action 
03/27/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
03/27/2025
04/03/2025
IV
240mg
OD
S/P CS With Hysterectomy + BTL
Waiting Final Action 
03/28/2025
CEFTRIAXONE 1G (VIAL)
03/28/2025
04/04/2025
IV
2g
OD
SP CS
Waiting Final Action 
04/01/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/01/2025
04/03/2025
IV
4.5g
Q6hr
Sp CS With Hysterectomy; TC HAP
Waiting Final Action 
04/01/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
04/01/2025
04/07/2025
IV
500mg
OD
Sp CS With Hysterectomy; RI HAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: